Inflammation

Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec in patients with wet age-related macular degeneration.

In this video exclusive, Deidra C. Crews, MD, ScM, FASN, president of the American Society of Nephrology discusses connections between kidney disease and obesity.

NEW YORK — In this Healio Video Perspective from OSN New York, Nandini Venkateswaran, MD, of Massachusetts Eye and Ear Infirmary, discusses real-world data investigating the use of Dextenza in patients with glaucoma.

A blood test to measure fibrinogen-to-albumin ratio predicted preeclampsia and severe preeclampsia risk in laboring women compared with other blood markers, potentially providing a useful tool for anesthesiologists, researchers reported.

The FDA granted fast track designation to FLQ-101 for the treatment of retinopathy of prematurity, according to a press release from FELIQS.

Decreasing the amount of dexamethasone that individuals with newly diagnosed multiple myeloma received did not affect survival, according to a secondary analysis of completed clinical trials.

BOSTON — Patients with eosinophilic reactive airway disease after immune checkpoint inhibitor therapy saw improved symptoms with typical treatment for reactive airway disease, according to a study presented at the CHEST Annual Meeting.

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

BOSTON — Receiving dupilumab for 52 weeks led to health-related quality of life improvement in adults with COPD and type 2 inflammation, according to a pooled analysis of BOREAS and NOTUS presented at the CHEST Annual Meeting.

Researchers identify two key genes that contribute to the pathogenesis of acne, potentially opening doors for new treatment approaches, according to a study.